Viatris Inc (VTRS): Total Assets
$37.19B
As of 2025-12-31
$35.04B
As of 2026-06-30
-9.4%
3-year compound annual growth
-9.6%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $37.19B | -10.4% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $41.50B | -13.0% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $47.69B | -4.7% | 2025-02-27, Balance as of period end |
| 2022-12-31 | $50.02B | -8.8% | 2024-02-28, Balance as of period end |
| 2021-12-31 | $54.84B | -10.9% | 2023-02-27, Balance as of period end |
| 2020-12-31 | $61.55B | +96.9% | 2022-02-28, Balance as of period end |
| 2019-12-31 | $31.26B | n/a | 2021-03-01, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Viatris Inc (VTRS) | 2025-12-31 | $37.19B | -10.4% |
| Regeneron Pharmaceuticals, Inc. (REGN) | 2025-12-31 | $40.56B | +7.4% |
| Vertex Pharmaceuticals Inc (VRTX) | 2025-12-31 | $25.64B | +13.8% |
| Teva Pharmaceutical Industries Ltd (TEVA) | 2025-12-31 | $40.75B | +3.6% |
| Bausch Health Companies Inc. (BHC) | 2025-12-31 | $26.37B | -0.6% |
| Zoetis Inc. (ZTS) | 2025-12-31 | $15.47B | +8.6% |
| Organon & Co. (OGN) | 2025-12-31 | $12.87B | -1.8% |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $8.19B | +38.3% |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $13.36B | +5.9% |
Compare VTRS, REGN, VRTX, TEVA side by side · Screen every company in Pharmaceutical Preparations ↗